1,028 top medical experts on Endophthalmitis across 46 countries and 36 U.S. states, including 990 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Endophthalmitis: Suppurative inflammation of the tissues of the internal structures of the eye frequently associated with an infection.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Eye Infections (1,015) and Narrower Categories: Suppurative Uveitis (29).
  4. Clinical Trials ClinicalTrials.gov : at least 43 including 3 Active, 17 Completed, 7 Recruiting
  5. Synonyms: Ophthalmia


  

        

                    


    These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

  1. Flynn, Harry W   Ophthalmology   Google Publications
    Miami, Florida, USA.
    Physician  Highly Cited  Highly Published  Case Reports  Review 
    Disclosed payments in 2021 from 2 biomedical companies, totalling $1,782.09, including $1,782.09 from  Alcon Vision LLC
    Subjects: Eye Infections, Bacterial; Anti-Bacterial Agents; Angiogenesis Inhibitors; Bacteria; Eye Infections, Fungal
    Categories: Microbiology; Adverse Effects; Therapeutic Use; Isolation & Purification; Epidemiology; Diagnosis

  2. Garg, Sunir J   Ophthalmology   Google Publications
    Mid Atlantic Retina, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.
    Physician  Highly Cited  Highly Published  Clinical Trial  Case Reports 
    Medical school: University of Michigan Medical School (MD, 1998)
    Disclosed payments in 2021 from 12 biomedical companies, totalling $18,248.25, including $6,500 from  Boehringer Ingelheim International GmbH
    Subjects: Eye Infections, Bacterial; Angiogenesis Inhibitors; Vitrectomy; Bacteria; Anti-Bacterial Agents
    Categories: Microbiology; Diagnosis; Adverse Effects; Epidemiology; Prevention & Control; Administration & Dosage

  3. Albini, Thomas A   Ophthalmology   Google Publications
    Bascom Palmer Eye Institute, The University of Miami, Miami, Florida.
    Physician  Highly Cited  Highly Published  Clinical Trial  Case Reports 
    Medical school: Johns Hopkins University School of Medicine (MD, 1999)
    Disclosed payments in 2021 from 29 biomedical companies, totalling $33,808.77, including $15,654.29 from  Bausch & Lomb, a division of Bausch Health US, LLC
    Subjects: Eye Infections, Bacterial; Anti-Bacterial Agents; Eye Infections, Fungal; Angiogenesis Inhibitors; Bacteremia
    Categories: Microbiology; Epidemiology; Etiology; Therapeutic Use; Adverse Effects; Diagnosis

  4. Durand, Marlene L   Internal Medicine   Google Publications
    Departments of Medicine and Ophthalmology, Harvard Medical School, and Infectious Disease Service, Massachusetts Eye and Ear Infirmary, and Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA . Top Hospital
    Physician  Highly Cited  Highly Published  Case Reports 
    Medical school: Harvard Medical School (MD, 1981)
    Medicare Accepted
    Subjects: Mycoses; Bacterial Infections; Eye Infections, Bacterial; Eye Infections, Fungal; Vitreous Body
    Categories: Microbiology; Epidemiology; Adverse Effects; Isolation & Purification; Pathology; Therapy

  5. Storey, Philip P   Ophthalmology   Google Publications
    Austin Retina Associates, Austin, Texas.
    Physician  Highly Cited  Highly Published  Case Reports 
    Disclosed payments in 2021 from 5 biomedical companies, totalling $738.41, including $588.48 from  Genentech USA, Inc.
    Subjects: Eye Infections, Bacterial; Angiogenesis Inhibitors; Intravitreal Injections; Anti-Bacterial Agents; Bacteria
    Categories: Epidemiology; Adverse Effects; Microbiology; Therapeutic Use; Administration & Dosage; Etiology

  6. Srivastava, Sunil K   Ophthalmology  Google Publications
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio.
    Physician  Highly Cited  Clinical Trial  Case Reports 
    Medical school: State University of New York at Buffalo School of Medicine (MD, 1998)
    Medicare Accepted
    Disclosed payments in 2021 from 48 biomedical companies, totalling $56,151.77, including $27,576.48 from  Bausch & Lomb, a division of Bausch Health US, LLC
    Subjects: Eye Infections, Bacterial; Staphylococcal Infections; Abscess; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized
    Categories: Diagnosis; Etiology; Microbiology; Isolation & Purification; Adverse Effects; Complications

  7. Murray, Timothy G   Ophthalmology  Google Publications
    Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida.
    Physician  Highly Cited  Clinical Trial  Case Reports 
    Disclosed payments in 2021 from 17 biomedical companies, totalling $20,655.65, including $16,304.25 from  Alcon Vision LLC
    Subjects: Eye Infections, Bacterial; Eye Infections, Fungal; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bacteria
    Categories: Microbiology; Adverse Effects; Etiology; Isolation & Purification; Antagonists & Inhibitors; Complications

  8. Shah, Chirag P   Ophthalmology  Google Publications
    Ophthalmic Consultants of Boston, Boston, Massachusetts.
    Physician  Highly Cited  Highly Published 
    Disclosed payments in 2021 from 4 biomedical companies, totalling $3,500.43, including $3,405.41 from  Regeneron Pharmaceuticals, Inc.
    Subjects: Angiogenesis Inhibitors; Eye Infections, Bacterial; Visual Acuity; Vitrectomy; Anti-Bacterial Agents
    Categories: Adverse Effects; Epidemiology; Microbiology; Administration & Dosage; Drug Therapy; Prevention & Control

  9. Vander, James F   Ophthalmology   Google Publications
    Wills Eye Hospital, Mid Atlantic Retina, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
    Physician  Highly Cited  Highly Published  Case Reports 
    Medical school: University of Michigan Medical School (MD, 1984)
    Subjects: Eye Infections, Bacterial; Angiogenesis Inhibitors; Intravitreal Injections; Anti-Bacterial Agents; Bacteria
    Categories: Microbiology; Adverse Effects; Prevention & Control; Therapeutic Use; Etiology; Isolation & Purification

  10. Wolfe, Jeremy D   Ophthalmology  Google Publications
    Associated Retinal Consultants, Royal Oak, Michigan.
    Physician  Highly Cited  Highly Published 
    Disclosed payments in 2021 from 36 biomedical companies, totalling $56,007.37, including $21,043.35 from  Regeneron Healthcare Solutions, Inc.
    Subjects: Angiogenesis Inhibitors; Eye Infections, Bacterial; Intravitreal Injections; Visual Acuity; Vitrectomy
    Categories: Epidemiology; Administration & Dosage; Adverse Effects; Methods; Prevention & Control; Drug Therapy

  11. Davis, Janet L   Ophthalmology   Google Publications
    Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida.
    Physician  Highly Cited  Highly Published  Case Reports 
    Medical school: Baylor College of Medicine (MD, 1981)
    Subjects: Eye Infections, Bacterial; Angiogenesis Inhibitors; Anti-Bacterial Agents; Bacteria; Cataract Extraction
    Categories: Microbiology; Isolation & Purification; Etiology; Therapeutic Use; Adverse Effects; Administration & Dosage

  12. Yonekawa, Yoshihiro   Ophthalmology   Google Publications
    Mid Atlantic Retina, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania. Electronic address: .
    Physician  Highly Cited  Highly Published  Case Reports 
    Disclosed payments in 2021 from 7 biomedical companies, totalling $11,664.2, including $7,350 from  Alcon Vision LLC
    Subjects: Eye Infections, Bacterial; Visual Acuity; Vitrectomy; Angiogenesis Inhibitors; Anti-Bacterial Agents
    Categories: Administration & Dosage; Epidemiology; Microbiology; Surgery; Adverse Effects; Isolation & Purification

  13. Kaiser, Richard S   Ophthalmology   Google Publications
    Mid Atlantic Retina, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.
    Physician  Highly Cited  Highly Published 
    Medical school: New York University School of Medicine (MD, 1995)
    Subjects: Angiogenesis Inhibitors; Eye Infections, Bacterial; Microsurgery; Vascular Endothelial Growth Factor A; Vitrectomy
    Categories: Microbiology; Adverse Effects; Methods; Administration & Dosage; Standards; Surgery

  14. Prenner, Jonathan L   Ophthalmology  Google Publications
    Rutgers Robert Wood Johnson Medical School, NJ Retina, New Brunswick, New Jersey, USA.
    Physician  Clinical Trial 
    Medical school: State University of New York at Stony Brook, School of Medicine (MD, 1998)
    Disclosed payments in 2021 from 6 biomedical companies, totalling $6,181.33, including $3,750 from  Dutch Ophthalmic, USA
    Subjects: Angiogenesis Inhibitors; Eye Infections, Bacterial; Microsurgery; Vitrectomy; Bevacizumab
    Categories: Epidemiology; Standards; Administration & Dosage; Methods; Adverse Effects; Antagonists & Inhibitors

  15. Chang, David F   Ophthalmology   Google Publications
    Altos Eye Physicians, Los Altos, California, USA.
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Disclosed payments in 2021 from 35 biomedical companies, totalling $14,594.89, including $6,070.3 from  Carl Zeiss Meditec, Inc.
    Subjects: Eye Infections, Bacterial; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Phacoemulsification
    Categories: Prevention & Control; Therapeutic Use; Adverse Effects; Drug Effects; Administration & Dosage; Epidemiology

  16. Ho, Allen C   Ophthalmology  Google Publications
    Mid Atlantic Retina, The Retina Service of Wills Eye Hospital, Philadelphia, Pennsylvania, USA.
    Physician  Highly Cited  Highly Published 
    Medical school: Columbia University College of Physicians and Surgeons (MD, 1988)
    Disclosed payments in 2021 from 26 biomedical companies, totalling $70,675.11, including $36,750 from  Rapid Pathogen Screening, Inc.
    Subjects: Eye Infections, Bacterial; Vitrectomy; Cataract Extraction; Microsurgery; Surgical Wound Infection
    Categories: Adverse Effects; Epidemiology; Etiology; Methods; Standards; Prevention & Control

  17. Kuriyan, Ajay E   Ophthalmology   Google Publications
    Mid Atlantic Retina, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.
    Physician  Highly Cited  Highly Published 
    Disclosed payments in 2021 from 19 biomedical companies, totalling $18,742.68, including $10,124.22 from  Spark Therapeutics, Inc.
    Subjects: Eye Infections, Bacterial; Anti-Bacterial Agents; Bacteria; Vitreous Body; Gram-Positive Bacterial Infections
    Categories: Microbiology; Isolation & Purification; Therapeutic Use; Diagnosis; Adverse Effects; Etiology

  18. Ambati, Balamurali Krishna   Ophthalmology   Google Publications
    Department of Ophthalmology, University of Utah, Salt Lake City, Utah, USA. Top Hospital
    Physician  Review 
    Disclosed payments in 2021 from 16 biomedical companies, totalling $618.94, including $195.73 from  Eyevance Pharmaceuticals LLC
    Subjects: Anti-Bacterial Agents; Antibiotic Prophylaxis; Anterior Chamber; Cataract Extraction; Cefuroxime
    Categories: Administration & Dosage; Prevention & Control; Adverse Effects; Methods; Drug Effects

  19. Fine, Howard F   Ophthalmology  Google Publications
    Department of Ophthalmology, Rutgers Robert Wood Johnson Medical School, 10 Plum Street Suite 600, New Brunswick NJ 08901, USA.
    Physician 
    Medical school: Harvard Medical School (MD, 2001)
    Disclosed payments in 2021 from 4 biomedical companies, totalling $11,427.13, including $11,275 from  Novartis Pharma AG
    Subjects: Angiogenesis Inhibitors; Eye Infections, Bacterial; Pharmaceutical Preparations; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins
    Categories: Adverse Effects; Prevention & Control; Administration & Dosage; Antagonists & Inhibitors; Chemically Induced; Epidemiology

  20. Moshfeghi, Andrew A   Ophthalmology   Google Publications
    Keck School of Medicine, USC Roski Eye Institute, University of Southern California, Los Angeles, California. Top Hospital
    Physician  Highly Cited  Highly Published 
    Medical school: Tulane University School of Medicine (MD, 1999)
    Disclosed payments in 2021 from 23 biomedical companies, totalling $301,925.46, including $293,024 from  Ocular Therapeutix, Inc.
    Subjects: Eye Infections, Bacterial; Angiogenesis Inhibitors; Vascular Endothelial Growth Factor A; Bacteremia; Eye Infections, Fungal
    Categories: Epidemiology; Administration & Dosage; Antagonists & Inhibitors; Drug Therapy; Adverse Effects; Etiology

Note:
  1. Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.
These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads or screen scraping) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

);